Global Chondroprotective Agent Supply, Demand and Key Producers, 2023-2029

Description

The global Chondroprotective Agent market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Chondroprotective Agent production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Chondroprotective Agent, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Chondroprotective Agent that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Chondroprotective Agent total production and demand, 2018-2029, (K Units)
Global Chondroprotective Agent total production value, 2018-2029, (USD Million)
Global Chondroprotective Agent production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Chondroprotective Agent consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Chondroprotective Agent domestic production, consumption, key domestic manufacturers and share
Global Chondroprotective Agent production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Chondroprotective Agent production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Chondroprotective Agent production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Chondroprotective Agent market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SANXIN, WanTuMing Biological, TSI Group, Yantai Dongcheng, Focus Chem, YBCC, Runxin Biotechnology, ISBA and Huiwen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Chondroprotective Agent market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Chondroprotective Agent Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Chondroprotective Agent Market, Segmentation by Type
    Sodium Hyaluronate
    Glucosamine Sulfate
    Chondroitin Sulfate

Global Chondroprotective Agent Market, Segmentation by Application
    Hospital
    Ambulatory Surgery Center

Companies Profiled:
    SANXIN
    WanTuMing Biological
    TSI Group
    Yantai Dongcheng
    Focus Chem
    YBCC
    Runxin Biotechnology
    ISBA
    Huiwen
    QJBCHINA
    Meitek (Synutra International)
    Hengjie Bio-Pharmaceuticals
    Nippon Zoki
    GGI
    Summit Nutritionals
    Sioux Pharm
    Ruikangda Biochemical
    Guanglong Biochem
    Pacific Rainbow

Key Questions Answered
1. How big is the global Chondroprotective Agent market?
2. What is the demand of the global Chondroprotective Agent market?
3. What is the year over year growth of the global Chondroprotective Agent market?
4. What is the production and production value of the global Chondroprotective Agent market?
5. Who are the key producers in the global Chondroprotective Agent market?

Table of Contents

1 Supply Summary
    1.1 Chondroprotective Agent Introduction
    1.2 World Chondroprotective Agent Supply & Forecast
        1.2.1 World Chondroprotective Agent Production Value (2018 & 2022 & 2029)
        1.2.2 World Chondroprotective Agent Production (2018-2029)
        1.2.3 World Chondroprotective Agent Pricing Trends (2018-2029)
    1.3 World Chondroprotective Agent Production by Region (Based on Production Site)
        1.3.1 World Chondroprotective Agent Production Value by Region (2018-2029)
        1.3.2 World Chondroprotective Agent Production by Region (2018-2029)
        1.3.3 World Chondroprotective Agent Average Price by Region (2018-2029)
        1.3.4 North America Chondroprotective Agent Production (2018-2029)
        1.3.5 Europe Chondroprotective Agent Production (2018-2029)
        1.3.6 China Chondroprotective Agent Production (2018-2029)
        1.3.7 Japan Chondroprotective Agent Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Chondroprotective Agent Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Chondroprotective Agent Major Market Trends

2 Demand Summary
    2.1 World Chondroprotective Agent Demand (2018-2029)
    2.2 World Chondroprotective Agent Consumption by Region
        2.2.1 World Chondroprotective Agent Consumption by Region (2018-2023)
        2.2.2 World Chondroprotective Agent Consumption Forecast by Region (2024-2029)
    2.3 United States Chondroprotective Agent Consumption (2018-2029)
    2.4 China Chondroprotective Agent Consumption (2018-2029)
    2.5 Europe Chondroprotective Agent Consumption (2018-2029)
    2.6 Japan Chondroprotective Agent Consumption (2018-2029)
    2.7 South Korea Chondroprotective Agent Consumption (2018-2029)
    2.8 ASEAN Chondroprotective Agent Consumption (2018-2029)
    2.9 India Chondroprotective Agent Consumption (2018-2029)

3 World Chondroprotective Agent Manufacturers Competitive Analysis
    3.1 World Chondroprotective Agent Production Value by Manufacturer (2018-2023)
    3.2 World Chondroprotective Agent Production by Manufacturer (2018-2023)
    3.3 World Chondroprotective Agent Average Price by Manufacturer (2018-2023)
    3.4 Chondroprotective Agent Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Chondroprotective Agent Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Chondroprotective Agent in 2022
        3.5.3 Global Concentration Ratios (CR8) for Chondroprotective Agent in 2022
    3.6 Chondroprotective Agent Market: Overall Company Footprint Analysis
        3.6.1 Chondroprotective Agent Market: Region Footprint
        3.6.2 Chondroprotective Agent Market: Company Product Type Footprint
        3.6.3 Chondroprotective Agent Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Chondroprotective Agent Production Value Comparison
        4.1.1 United States VS China: Chondroprotective Agent Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Chondroprotective Agent Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Chondroprotective Agent Production Comparison
        4.2.1 United States VS China: Chondroprotective Agent Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Chondroprotective Agent Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Chondroprotective Agent Consumption Comparison
        4.3.1 United States VS China: Chondroprotective Agent Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Chondroprotective Agent Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Chondroprotective Agent Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Chondroprotective Agent Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Chondroprotective Agent Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Chondroprotective Agent Production (2018-2023)
    4.5 China Based Chondroprotective Agent Manufacturers and Market Share
        4.5.1 China Based Chondroprotective Agent Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Chondroprotective Agent Production Value (2018-2023)
        4.5.3 China Based Manufacturers Chondroprotective Agent Production (2018-2023)
    4.6 Rest of World Based Chondroprotective Agent Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Chondroprotective Agent Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Chondroprotective Agent Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Chondroprotective Agent Production (2018-2023)

5 Market Analysis by Type
    5.1 World Chondroprotective Agent Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Sodium Hyaluronate
        5.2.2 Glucosamine Sulfate
        5.2.3 Chondroitin Sulfate
    5.3 Market Segment by Type
        5.3.1 World Chondroprotective Agent Production by Type (2018-2029)
        5.3.2 World Chondroprotective Agent Production Value by Type (2018-2029)
        5.3.3 World Chondroprotective Agent Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Chondroprotective Agent Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Ambulatory Surgery Center
    6.3 Market Segment by Application
        6.3.1 World Chondroprotective Agent Production by Application (2018-2029)
        6.3.2 World Chondroprotective Agent Production Value by Application (2018-2029)
        6.3.3 World Chondroprotective Agent Average Price by Application (2018-2029)

7 Company Profiles
    7.1 SANXIN
        7.1.1 SANXIN Details
        7.1.2 SANXIN Major Business
        7.1.3 SANXIN Chondroprotective Agent Product and Services
        7.1.4 SANXIN Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 SANXIN Recent Developments/Updates
        7.1.6 SANXIN Competitive Strengths & Weaknesses
    7.2 WanTuMing Biological
        7.2.1 WanTuMing Biological Details
        7.2.2 WanTuMing Biological Major Business
        7.2.3 WanTuMing Biological Chondroprotective Agent Product and Services
        7.2.4 WanTuMing Biological Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 WanTuMing Biological Recent Developments/Updates
        7.2.6 WanTuMing Biological Competitive Strengths & Weaknesses
    7.3 TSI Group
        7.3.1 TSI Group Details
        7.3.2 TSI Group Major Business
        7.3.3 TSI Group Chondroprotective Agent Product and Services
        7.3.4 TSI Group Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 TSI Group Recent Developments/Updates
        7.3.6 TSI Group Competitive Strengths & Weaknesses
    7.4 Yantai Dongcheng
        7.4.1 Yantai Dongcheng Details
        7.4.2 Yantai Dongcheng Major Business
        7.4.3 Yantai Dongcheng Chondroprotective Agent Product and Services
        7.4.4 Yantai Dongcheng Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Yantai Dongcheng Recent Developments/Updates
        7.4.6 Yantai Dongcheng Competitive Strengths & Weaknesses
    7.5 Focus Chem
        7.5.1 Focus Chem Details
        7.5.2 Focus Chem Major Business
        7.5.3 Focus Chem Chondroprotective Agent Product and Services
        7.5.4 Focus Chem Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Focus Chem Recent Developments/Updates
        7.5.6 Focus Chem Competitive Strengths & Weaknesses
    7.6 YBCC
        7.6.1 YBCC Details
        7.6.2 YBCC Major Business
        7.6.3 YBCC Chondroprotective Agent Product and Services
        7.6.4 YBCC Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 YBCC Recent Developments/Updates
        7.6.6 YBCC Competitive Strengths & Weaknesses
    7.7 Runxin Biotechnology
        7.7.1 Runxin Biotechnology Details
        7.7.2 Runxin Biotechnology Major Business
        7.7.3 Runxin Biotechnology Chondroprotective Agent Product and Services
        7.7.4 Runxin Biotechnology Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Runxin Biotechnology Recent Developments/Updates
        7.7.6 Runxin Biotechnology Competitive Strengths & Weaknesses
    7.8 ISBA
        7.8.1 ISBA Details
        7.8.2 ISBA Major Business
        7.8.3 ISBA Chondroprotective Agent Product and Services
        7.8.4 ISBA Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 ISBA Recent Developments/Updates
        7.8.6 ISBA Competitive Strengths & Weaknesses
    7.9 Huiwen
        7.9.1 Huiwen Details
        7.9.2 Huiwen Major Business
        7.9.3 Huiwen Chondroprotective Agent Product and Services
        7.9.4 Huiwen Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Huiwen Recent Developments/Updates
        7.9.6 Huiwen Competitive Strengths & Weaknesses
    7.10 QJBCHINA
        7.10.1 QJBCHINA Details
        7.10.2 QJBCHINA Major Business
        7.10.3 QJBCHINA Chondroprotective Agent Product and Services
        7.10.4 QJBCHINA Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 QJBCHINA Recent Developments/Updates
        7.10.6 QJBCHINA Competitive Strengths & Weaknesses
    7.11 Meitek (Synutra International)
        7.11.1 Meitek (Synutra International) Details
        7.11.2 Meitek (Synutra International) Major Business
        7.11.3 Meitek (Synutra International) Chondroprotective Agent Product and Services
        7.11.4 Meitek (Synutra International) Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Meitek (Synutra International) Recent Developments/Updates
        7.11.6 Meitek (Synutra International) Competitive Strengths & Weaknesses
    7.12 Hengjie Bio-Pharmaceuticals
        7.12.1 Hengjie Bio-Pharmaceuticals Details
        7.12.2 Hengjie Bio-Pharmaceuticals Major Business
        7.12.3 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Product and Services
        7.12.4 Hengjie Bio-Pharmaceuticals Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Hengjie Bio-Pharmaceuticals Recent Developments/Updates
        7.12.6 Hengjie Bio-Pharmaceuticals Competitive Strengths & Weaknesses
    7.13 Nippon Zoki
        7.13.1 Nippon Zoki Details
        7.13.2 Nippon Zoki Major Business
        7.13.3 Nippon Zoki Chondroprotective Agent Product and Services
        7.13.4 Nippon Zoki Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Nippon Zoki Recent Developments/Updates
        7.13.6 Nippon Zoki Competitive Strengths & Weaknesses
    7.14 GGI
        7.14.1 GGI Details
        7.14.2 GGI Major Business
        7.14.3 GGI Chondroprotective Agent Product and Services
        7.14.4 GGI Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 GGI Recent Developments/Updates
        7.14.6 GGI Competitive Strengths & Weaknesses
    7.15 Summit Nutritionals
        7.15.1 Summit Nutritionals Details
        7.15.2 Summit Nutritionals Major Business
        7.15.3 Summit Nutritionals Chondroprotective Agent Product and Services
        7.15.4 Summit Nutritionals Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Summit Nutritionals Recent Developments/Updates
        7.15.6 Summit Nutritionals Competitive Strengths & Weaknesses
    7.16 Sioux Pharm
        7.16.1 Sioux Pharm Details
        7.16.2 Sioux Pharm Major Business
        7.16.3 Sioux Pharm Chondroprotective Agent Product and Services
        7.16.4 Sioux Pharm Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Sioux Pharm Recent Developments/Updates
        7.16.6 Sioux Pharm Competitive Strengths & Weaknesses
    7.17 Ruikangda Biochemical
        7.17.1 Ruikangda Biochemical Details
        7.17.2 Ruikangda Biochemical Major Business
        7.17.3 Ruikangda Biochemical Chondroprotective Agent Product and Services
        7.17.4 Ruikangda Biochemical Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.17.5 Ruikangda Biochemical Recent Developments/Updates
        7.17.6 Ruikangda Biochemical Competitive Strengths & Weaknesses
    7.18 Guanglong Biochem
        7.18.1 Guanglong Biochem Details
        7.18.2 Guanglong Biochem Major Business
        7.18.3 Guanglong Biochem Chondroprotective Agent Product and Services
        7.18.4 Guanglong Biochem Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.18.5 Guanglong Biochem Recent Developments/Updates
        7.18.6 Guanglong Biochem Competitive Strengths & Weaknesses
    7.19 Pacific Rainbow
        7.19.1 Pacific Rainbow Details
        7.19.2 Pacific Rainbow Major Business
        7.19.3 Pacific Rainbow Chondroprotective Agent Product and Services
        7.19.4 Pacific Rainbow Chondroprotective Agent Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.19.5 Pacific Rainbow Recent Developments/Updates
        7.19.6 Pacific Rainbow Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Chondroprotective Agent Industry Chain
    8.2 Chondroprotective Agent Upstream Analysis
        8.2.1 Chondroprotective Agent Core Raw Materials
        8.2.2 Main Manufacturers of Chondroprotective Agent Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Chondroprotective Agent Production Mode
    8.6 Chondroprotective Agent Procurement Model
    8.7 Chondroprotective Agent Industry Sales Model and Sales Channels
        8.7.1 Chondroprotective Agent Sales Model
        8.7.2 Chondroprotective Agent Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Chondroprotective Agent Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Chondroprotective Agent Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Chondroprotective Agent Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Chondroprotective Agent Production Value Market Share by Region (2018-2023)
    Table 5. World Chondroprotective Agent Production Value Market Share by Region (2024-2029)
    Table 6. World Chondroprotective Agent Production by Region (2018-2023) & (K Units)
    Table 7. World Chondroprotective Agent Production by Region (2024-2029) & (K Units)
    Table 8. World Chondroprotective Agent Production Market Share by Region (2018-2023)
    Table 9. World Chondroprotective Agent Production Market Share by Region (2024-2029)
    Table 10. World Chondroprotective Agent Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Chondroprotective Agent Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Chondroprotective Agent Major Market Trends
    Table 13. World Chondroprotective Agent Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Chondroprotective Agent Consumption by Region (2018-2023) & (K Units)
    Table 15. World Chondroprotective Agent Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Chondroprotective Agent Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Chondroprotective Agent Producers in 2022
    Table 18. World Chondroprotective Agent Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Chondroprotective Agent Producers in 2022
    Table 20. World Chondroprotective Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Chondroprotective Agent Company Evaluation Quadrant
    Table 22. World Chondroprotective Agent Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Chondroprotective Agent Production Site of Key Manufacturer
    Table 24. Chondroprotective Agent Market: Company Product Type Footprint
    Table 25. Chondroprotective Agent Market: Company Product Application Footprint
    Table 26. Chondroprotective Agent Competitive Factors
    Table 27. Chondroprotective Agent New Entrant and Capacity Expansion Plans
    Table 28. Chondroprotective Agent Mergers & Acquisitions Activity
    Table 29. United States VS China Chondroprotective Agent Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Chondroprotective Agent Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Chondroprotective Agent Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Chondroprotective Agent Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Chondroprotective Agent Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Chondroprotective Agent Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Chondroprotective Agent Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Chondroprotective Agent Production Market Share (2018-2023)
    Table 37. China Based Chondroprotective Agent Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Chondroprotective Agent Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Chondroprotective Agent Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Chondroprotective Agent Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Chondroprotective Agent Production Market Share (2018-2023)
    Table 42. Rest of World Based Chondroprotective Agent Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Chondroprotective Agent Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Chondroprotective Agent Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Chondroprotective Agent Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Chondroprotective Agent Production Market Share (2018-2023)
    Table 47. World Chondroprotective Agent Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Chondroprotective Agent Production by Type (2018-2023) & (K Units)
    Table 49. World Chondroprotective Agent Production by Type (2024-2029) & (K Units)
    Table 50. World Chondroprotective Agent Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Chondroprotective Agent Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Chondroprotective Agent Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Chondroprotective Agent Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Chondroprotective Agent Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Chondroprotective Agent Production by Application (2018-2023) & (K Units)
    Table 56. World Chondroprotective Agent Production by Application (2024-2029) & (K Units)
    Table 57. World Chondroprotective Agent Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Chondroprotective Agent Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Chondroprotective Agent Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Chondroprotective Agent Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. SANXIN Basic Information, Manufacturing Base and Competitors
    Table 62. SANXIN Major Business
    Table 63. SANXIN Chondroprotective Agent Product and Services
    Table 64. SANXIN Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. SANXIN Recent Developments/Updates
    Table 66. SANXIN Competitive Strengths & Weaknesses
    Table 67. WanTuMing Biological Basic Information, Manufacturing Base and Competitors
    Table 68. WanTuMing Biological Major Business
    Table 69. WanTuMing Biological Chondroprotective Agent Product and Services
    Table 70. WanTuMing Biological Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. WanTuMing Biological Recent Developments/Updates
    Table 72. WanTuMing Biological Competitive Strengths & Weaknesses
    Table 73. TSI Group Basic Information, Manufacturing Base and Competitors
    Table 74. TSI Group Major Business
    Table 75. TSI Group Chondroprotective Agent Product and Services
    Table 76. TSI Group Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. TSI Group Recent Developments/Updates
    Table 78. TSI Group Competitive Strengths & Weaknesses
    Table 79. Yantai Dongcheng Basic Information, Manufacturing Base and Competitors
    Table 80. Yantai Dongcheng Major Business
    Table 81. Yantai Dongcheng Chondroprotective Agent Product and Services
    Table 82. Yantai Dongcheng Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Yantai Dongcheng Recent Developments/Updates
    Table 84. Yantai Dongcheng Competitive Strengths & Weaknesses
    Table 85. Focus Chem Basic Information, Manufacturing Base and Competitors
    Table 86. Focus Chem Major Business
    Table 87. Focus Chem Chondroprotective Agent Product and Services
    Table 88. Focus Chem Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Focus Chem Recent Developments/Updates
    Table 90. Focus Chem Competitive Strengths & Weaknesses
    Table 91. YBCC Basic Information, Manufacturing Base and Competitors
    Table 92. YBCC Major Business
    Table 93. YBCC Chondroprotective Agent Product and Services
    Table 94. YBCC Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. YBCC Recent Developments/Updates
    Table 96. YBCC Competitive Strengths & Weaknesses
    Table 97. Runxin Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 98. Runxin Biotechnology Major Business
    Table 99. Runxin Biotechnology Chondroprotective Agent Product and Services
    Table 100. Runxin Biotechnology Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Runxin Biotechnology Recent Developments/Updates
    Table 102. Runxin Biotechnology Competitive Strengths & Weaknesses
    Table 103. ISBA Basic Information, Manufacturing Base and Competitors
    Table 104. ISBA Major Business
    Table 105. ISBA Chondroprotective Agent Product and Services
    Table 106. ISBA Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. ISBA Recent Developments/Updates
    Table 108. ISBA Competitive Strengths & Weaknesses
    Table 109. Huiwen Basic Information, Manufacturing Base and Competitors
    Table 110. Huiwen Major Business
    Table 111. Huiwen Chondroprotective Agent Product and Services
    Table 112. Huiwen Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Huiwen Recent Developments/Updates
    Table 114. Huiwen Competitive Strengths & Weaknesses
    Table 115. QJBCHINA Basic Information, Manufacturing Base and Competitors
    Table 116. QJBCHINA Major Business
    Table 117. QJBCHINA Chondroprotective Agent Product and Services
    Table 118. QJBCHINA Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. QJBCHINA Recent Developments/Updates
    Table 120. QJBCHINA Competitive Strengths & Weaknesses
    Table 121. Meitek (Synutra International) Basic Information, Manufacturing Base and Competitors
    Table 122. Meitek (Synutra International) Major Business
    Table 123. Meitek (Synutra International) Chondroprotective Agent Product and Services
    Table 124. Meitek (Synutra International) Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Meitek (Synutra International) Recent Developments/Updates
    Table 126. Meitek (Synutra International) Competitive Strengths & Weaknesses
    Table 127. Hengjie Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 128. Hengjie Bio-Pharmaceuticals Major Business
    Table 129. Hengjie Bio-Pharmaceuticals Chondroprotective Agent Product and Services
    Table 130. Hengjie Bio-Pharmaceuticals Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Hengjie Bio-Pharmaceuticals Recent Developments/Updates
    Table 132. Hengjie Bio-Pharmaceuticals Competitive Strengths & Weaknesses
    Table 133. Nippon Zoki Basic Information, Manufacturing Base and Competitors
    Table 134. Nippon Zoki Major Business
    Table 135. Nippon Zoki Chondroprotective Agent Product and Services
    Table 136. Nippon Zoki Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Nippon Zoki Recent Developments/Updates
    Table 138. Nippon Zoki Competitive Strengths & Weaknesses
    Table 139. GGI Basic Information, Manufacturing Base and Competitors
    Table 140. GGI Major Business
    Table 141. GGI Chondroprotective Agent Product and Services
    Table 142. GGI Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. GGI Recent Developments/Updates
    Table 144. GGI Competitive Strengths & Weaknesses
    Table 145. Summit Nutritionals Basic Information, Manufacturing Base and Competitors
    Table 146. Summit Nutritionals Major Business
    Table 147. Summit Nutritionals Chondroprotective Agent Product and Services
    Table 148. Summit Nutritionals Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Summit Nutritionals Recent Developments/Updates
    Table 150. Summit Nutritionals Competitive Strengths & Weaknesses
    Table 151. Sioux Pharm Basic Information, Manufacturing Base and Competitors
    Table 152. Sioux Pharm Major Business
    Table 153. Sioux Pharm Chondroprotective Agent Product and Services
    Table 154. Sioux Pharm Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 155. Sioux Pharm Recent Developments/Updates
    Table 156. Sioux Pharm Competitive Strengths & Weaknesses
    Table 157. Ruikangda Biochemical Basic Information, Manufacturing Base and Competitors
    Table 158. Ruikangda Biochemical Major Business
    Table 159. Ruikangda Biochemical Chondroprotective Agent Product and Services
    Table 160. Ruikangda Biochemical Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 161. Ruikangda Biochemical Recent Developments/Updates
    Table 162. Ruikangda Biochemical Competitive Strengths & Weaknesses
    Table 163. Guanglong Biochem Basic Information, Manufacturing Base and Competitors
    Table 164. Guanglong Biochem Major Business
    Table 165. Guanglong Biochem Chondroprotective Agent Product and Services
    Table 166. Guanglong Biochem Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 167. Guanglong Biochem Recent Developments/Updates
    Table 168. Pacific Rainbow Basic Information, Manufacturing Base and Competitors
    Table 169. Pacific Rainbow Major Business
    Table 170. Pacific Rainbow Chondroprotective Agent Product and Services
    Table 171. Pacific Rainbow Chondroprotective Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 172. Global Key Players of Chondroprotective Agent Upstream (Raw Materials)
    Table 173. Chondroprotective Agent Typical Customers
    Table 174. Chondroprotective Agent Typical Distributors
List of Figure
    Figure 1. Chondroprotective Agent Picture
    Figure 2. World Chondroprotective Agent Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Chondroprotective Agent Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Chondroprotective Agent Production (2018-2029) & (K Units)
    Figure 5. World Chondroprotective Agent Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Chondroprotective Agent Production Value Market Share by Region (2018-2029)
    Figure 7. World Chondroprotective Agent Production Market Share by Region (2018-2029)
    Figure 8. North America Chondroprotective Agent Production (2018-2029) & (K Units)
    Figure 9. Europe Chondroprotective Agent Production (2018-2029) & (K Units)
    Figure 10. China Chondroprotective Agent Production (2018-2029) & (K Units)
    Figure 11. Japan Chondroprotective Agent Production (2018-2029) & (K Units)
    Figure 12. Chondroprotective Agent Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Chondroprotective Agent Consumption (2018-2029) & (K Units)
    Figure 15. World Chondroprotective Agent Consumption Market Share by Region (2018-2029)
    Figure 16. United States Chondroprotective Agent Consumption (2018-2029) & (K Units)
    Figure 17. China Chondroprotective Agent Consumption (2018-2029) & (K Units)
    Figure 18. Europe Chondroprotective Agent Consumption (2018-2029) & (K Units)
    Figure 19. Japan Chondroprotective Agent Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Chondroprotective Agent Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Chondroprotective Agent Consumption (2018-2029) & (K Units)
    Figure 22. India Chondroprotective Agent Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Chondroprotective Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Chondroprotective Agent Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Chondroprotective Agent Markets in 2022
    Figure 26. United States VS China: Chondroprotective Agent Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Chondroprotective Agent Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Chondroprotective Agent Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Chondroprotective Agent Production Market Share 2022
    Figure 30. China Based Manufacturers Chondroprotective Agent Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Chondroprotective Agent Production Market Share 2022
    Figure 32. World Chondroprotective Agent Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Chondroprotective Agent Production Value Market Share by Type in 2022
    Figure 34. Sodium Hyaluronate
    Figure 35. Glucosamine Sulfate
    Figure 36. Chondroitin Sulfate
    Figure 37. World Chondroprotective Agent Production Market Share by Type (2018-2029)
    Figure 38. World Chondroprotective Agent Production Value Market Share by Type (2018-2029)
    Figure 39. World Chondroprotective Agent Average Price by Type (2018-2029) & (US$/Unit)
    Figure 40. World Chondroprotective Agent Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Chondroprotective Agent Production Value Market Share by Application in 2022
    Figure 42. Hospital
    Figure 43. Ambulatory Surgery Center
    Figure 44. World Chondroprotective Agent Production Market Share by Application (2018-2029)
    Figure 45. World Chondroprotective Agent Production Value Market Share by Application (2018-2029)
    Figure 46. World Chondroprotective Agent Average Price by Application (2018-2029) & (US$/Unit)
    Figure 47. Chondroprotective Agent Industry Chain
    Figure 48. Chondroprotective Agent Procurement Model
    Figure 49. Chondroprotective Agent Sales Model
    Figure 50. Chondroprotective Agent Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Companies Mentioned

SANXIN
WanTuMing Biological
TSI Group
Yantai Dongcheng
Focus Chem
YBCC
Runxin Biotechnology
ISBA
Huiwen
QJBCHINA
Meitek (Synutra International)
Hengjie Bio-Pharmaceuticals
Nippon Zoki
GGI
Summit Nutritionals
Sioux Pharm
Ruikangda Biochemical
Guanglong Biochem
Pacific Rainbow